View in EDS HTML Full Text PDF Full Text

Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis.

Saved in:
Bibliographic Details
Title: Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis.
Authors: Evans, Denise1 (AUTHOR) devans@heroza.org, Hirasen, Kamban1,2 (AUTHOR), Ramushu, Clive1 (AUTHOR), Long, Lawrence1,3 (AUTHOR), Sinanovic, Edina2 (AUTHOR), Conradie, Francesca4 (AUTHOR), Howell, Pauline4 (AUTHOR), Padanilam, Xavier5 (AUTHOR), Ferreira, Hannetjie6 (AUTHOR), Variaiva, Ebrahim6 (AUTHOR), Rajaram, Shakira4 (AUTHOR), Gupta, Aastha7 (AUTHOR), Juneja, Sandeep7 (AUTHOR), Ndjeka, Norbert8 (AUTHOR)
Source: PLoS ONE. 10/21/2024, Vol. 19 Issue 10, p1-19. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0309034